{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:46:51Z","timestamp":1785847611297,"version":"3.56.0"},"reference-count":94,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"unspecified","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR22-10"],"award-info":[{"award-number":["W.OR22-10"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,16]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Congenital myopathies (CMYO) are a group of rare hereditary muscle diseases defined by characteristic abnormalities on muscle biopsy. Several types, including the core myopathies central core disease and multi-minicore disease, nemaline myopathy and centronuclear myopathy, have been identified based on the characteristic histopathological changes and attributed to various genetic backgrounds. The most prominent clinical features are generalised muscle weakness often pronounced axially, variable cardiorespiratory and bulbar impairment, and skeletal and joint involvement. Currently, no curative therapies are available for CMYOs; however, a few phase I and II trials have been performed or are expected in the near future. To reach trial readiness, an informed understanding of the disease course and a selection of relevant and sensitive clinical and functional outcome measures, and blood and imaging biomarkers is necessary. Furthermore, additional symptoms such as muscle fatigability have been recognised but not investigated systematically yet. The lack of understanding muscle fatigability in CMYO in particular calls for a cross-sectional study as this feature may be a treatment target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>In collaboration with patient representatives, two studies have been designed: (1) a prospective cohort study with five 6-monthly visits over a 2-year period; and (2) a cross-sectional study on muscle fatigability. For both studies, patients from the same study population will be included. We aim to include 45 patients in study 1 and 75 in study 2. Patients are invited to participate in both studies. In study 1, we will perform a range of assessments covering patient-reported outcomes, clinical and functional outcome measures, and blood and imaging biomarkers. For study 2, we will assess the muscle fatigability and neuromuscular junction transmission. Baseline data will be analysed using descriptive statistics and correlation analysis. To assess disease progression, mixed models will be used. Multiple linear regressions will be used to explore the relationship between potential disease-modifying variables and disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the Central Committee on Research Involving Human Subjects (CCMO, registration number NL83069.000.23). Findings will be shared with the participating patients and the funder. It will be presented at conferences and shared through peer-reviewed publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06157268\">NCT06157268<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-119529","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:56:27Z","timestamp":1785844587000},"page":"e119529","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["READYCOM: protocol for a 2-year prospective natural history and cross-sectional muscle-fatigability study for improving trial readiness in congenital myopathies"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06157268","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06157268","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03351270","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06287762","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04033159","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4028-1113","authenticated-orcid":false,"given":"Sanne A J H","family":"van de Camp","sequence":"first","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosmarijn","family":"Brenninkmeijer","sequence":"additional","affiliation":[{"name":"Child Development and Exercise Center, Wilhelmina Children\u2019s Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen L M","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth C M","family":"de Laat","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pomp","sequence":"additional","affiliation":[{"name":"Child Development and Exercise Center, Wilhelmina Children\u2019s Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizan","family":"Stinissen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnie","family":"Cameron","sequence":"additional","affiliation":[{"name":"Clinical Neuromuscular Imaging Group, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan T","family":"Groothuis","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nens","family":"van Alfen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Clinical Neuromuscular Imaging Group, Donders Center for Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Neuromuscular Service, Evelina London Children\u2019s Hospital, Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"},{"name":"Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie E","family":"Erasmus","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Donders Institute for Brain, Cognition and Behaviour, Amalia Children\u2019s Hospital, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Bartels","sequence":"additional","affiliation":[{"name":"Child Development and Exercise Center, Wilhelmina Children\u2019s Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske I","family":"Wadman","sequence":"additional","affiliation":[{"name":"Department of Neurology & Neurosurgery, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline B M","family":"Voet","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Rehabilitation Centre, Klimmendaal, Arnhem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Ludo","family":"van der Pol","sequence":"additional","affiliation":[{"name":"Department of Neurology & Neurosurgery, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C","family":"Voermans","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2026080404552160000_16.8.e119529.1","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-017-0419-z","article-title":"Congenital myopathies: clinical phenotypes and new diagnostic tools","volume":"43","author":"Cassandrini","year":"2017","journal-title":"Ital J Pediatr"},{"key":"2026080404552160000_16.8.e119529.2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.nmd.2014.07.005","article-title":"Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature","volume":"24","author":"Rodr\u00edguez Cruz","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"2026080404552160000_16.8.e119529.3","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.857959","article-title":"Corrigendum: A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy","volume":"13","author":"Huang","year":"2022","journal-title":"Front Neurol"},{"key":"2026080404552160000_16.8.e119529.4","doi-asserted-by":"publisher","DOI":"10.1038\/ng0993-51"},{"key":"2026080404552160000_16.8.e119529.5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl077"},{"key":"2026080404552160000_16.8.e119529.6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm096"},{"key":"2026080404552160000_16.8.e119529.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.01.016"},{"key":"2026080404552160000_16.8.e119529.8","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14054"},{"key":"2026080404552160000_16.8.e119529.9","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.32.9.673"},{"key":"2026080404552160000_16.8.e119529.10","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.34.9.705"},{"key":"2026080404552160000_16.8.e119529.11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/86.4.793"},{"key":"2026080404552160000_16.8.e119529.12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011458"},{"key":"2026080404552160000_16.8.e119529.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.07.012"},{"key":"2026080404552160000_16.8.e119529.14","doi-asserted-by":"publisher","DOI":"10.1016\/J.COPH.2022.102328"},{"key":"2026080404552160000_16.8.e119529.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.07.290"},{"key":"2026080404552160000_16.8.e119529.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102433","article-title":"Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial","volume":"68","author":"Todd","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026080404552160000_16.8.e119529.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146036","article-title":"Aerobic Training in Patients with Congenital Myopathy","volume":"11","author":"Hedermann","year":"2016","journal-title":"PLoS ONE"},{"key":"2026080404552160000_16.8.e119529.18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.nmd.2020.08.356","article-title":"250th ENMC International Workshop: Clinical trial readiness in nemaline myopathy 6\u20138 September 2019, Hoofdorp, the Netherlands","volume":"30","author":"Neuhaus","year":"2020","journal-title":"Neuromuscular Disorders"},{"key":"2026080404552160000_16.8.e119529.19","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.nmd.2021.08.003","article-title":"X-linked myotubular myopathy","volume":"31","author":"Lawlor","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"2026080404552160000_16.8.e119529.20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JND-221609","article-title":"RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022","volume":"10","author":"O\u2019Connor","year":"2023","journal-title":"J Neuromuscul Dis"},{"key":"2026080404552160000_16.8.e119529.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00313-7"},{"key":"2026080404552160000_16.8.e119529.22","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812436605"},{"key":"2026080404552160000_16.8.e119529.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2023.07.241","article-title":"P410 Liver involvement in myotubular and centronuclear Myopathy: data from the MTM & CNM patient registry","volume":"33","author":"Bullivant","year":"2023","journal-title":"Neuromuscular Disorders"},{"key":"2026080404552160000_16.8.e119529.24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"key":"2026080404552160000_16.8.e119529.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2011.02.012"},{"key":"2026080404552160000_16.8.e119529.26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827f07be"},{"key":"2026080404552160000_16.8.e119529.27","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1212\/WNL.0000000000011230","article-title":"Correlates of Fatigability in Patients With Spinal Muscular Atrophy","volume":"96","author":"Bartels","year":"2021","journal-title":"Neurology"},{"key":"2026080404552160000_16.8.e119529.28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182749eca"},{"key":"2026080404552160000_16.8.e119529.29","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac324","article-title":"Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4","volume":"5","author":"Stam","year":"2023","journal-title":"Brain Commun"},{"key":"2026080404552160000_16.8.e119529.30","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1007\/s10545-010-9085-7","article-title":"Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction","volume":"33 Suppl 3","author":"Schreuder","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"2026080404552160000_16.8.e119529.31","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26999"},{"key":"2026080404552160000_16.8.e119529.32","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1140"},{"key":"2026080404552160000_16.8.e119529.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-1348-2","article-title":"Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests","volume":"15","author":"Bartels","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2026080404552160000_16.8.e119529.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.02.013"},{"key":"2026080404552160000_16.8.e119529.35","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)90099-X"},{"key":"2026080404552160000_16.8.e119529.36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpsychores.2017.05.007","article-title":"The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength","volume":"98","author":"Worm-Smeitink","year":"2017","journal-title":"J Psychosom Res"},{"key":"2026080404552160000_16.8.e119529.37","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520460115022"},{"key":"2026080404552160000_16.8.e119529.38","doi-asserted-by":"publisher","DOI":"10.3109\/09638281003734458"},{"key":"2026080404552160000_16.8.e119529.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"2026080404552160000_16.8.e119529.40","doi-asserted-by":"publisher","DOI":"10.1191\/026921599668601325"},{"key":"2026080404552160000_16.8.e119529.41","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(87)90027-3"},{"key":"2026080404552160000_16.8.e119529.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2009.09.009"},{"key":"2026080404552160000_16.8.e119529.43","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9836-9"},{"key":"2026080404552160000_16.8.e119529.44","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-015-0966-y"},{"key":"2026080404552160000_16.8.e119529.45","first-page":"1733","article-title":"Dutch-Flemish translation of 17 item banks from the patient-reported outcomes measurement information system (PROMIS)","volume":"23","author":"Terwee","year":"2014","journal-title":"Qual Life Res"},{"key":"2026080404552160000_16.8.e119529.46","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00169","article-title":"Assessing Psychological Resilience: Development and Psychometric Properties of the English and Dutch Version of the Resilience Evaluation Scale (RES)","volume":"9","author":"van der Meer","year":"2018","journal-title":"Front Psychiatry"},{"key":"2026080404552160000_16.8.e119529.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00097-3"},{"key":"2026080404552160000_16.8.e119529.48","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0589"},{"key":"2026080404552160000_16.8.e119529.49","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e31820513be"},{"key":"2026080404552160000_16.8.e119529.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsams.2012.05.013"},{"key":"2026080404552160000_16.8.e119529.51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4187\/respcare.03480783","article-title":"The six-minute walk test","volume":"48","author":"Enright","year":"2003","journal-title":"Respir Care"},{"key":"2026080404552160000_16.8.e119529.52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ptj\/64.1.41","article-title":"Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures","volume":"64","author":"Florence","year":"1984","journal-title":"Phys Ther"},{"key":"2026080404552160000_16.8.e119529.53","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20654"},{"key":"2026080404552160000_16.8.e119529.54","doi-asserted-by":"publisher","DOI":"10.1249\/00005768-198205000-00012"},{"key":"2026080404552160000_16.8.e119529.55","doi-asserted-by":"publisher","DOI":"10.1080\/16501970510044043"},{"key":"2026080404552160000_16.8.e119529.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2005.03.004"},{"key":"2026080404552160000_16.8.e119529.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2013.04.001"},{"key":"2026080404552160000_16.8.e119529.58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02399.x"},{"key":"2026080404552160000_16.8.e119529.59","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01214-2018"},{"key":"2026080404552160000_16.8.e119529.60","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00137-2021","article-title":"Respiratory muscle imaging by ultrasound and MRI in neuromuscular disorders","volume":"58","author":"van Doorn","year":"2021","journal-title":"Eur Respir J"},{"key":"2026080404552160000_16.8.e119529.61","doi-asserted-by":"publisher","DOI":"10.1016\/S1607-551X(09)70523-6"},{"key":"2026080404552160000_16.8.e119529.62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5535\/arm.2012.36.1.22","article-title":"The correlation analysis of functional factors and age with duchenne muscular dystrophy","volume":"36","author":"Jung","year":"2012","journal-title":"Ann Rehabil Med"},{"key":"2026080404552160000_16.8.e119529.63","unstructured":"Santini F , Wasserthal J , Agosti A , et al . Deep anatomical federated network (dafne): an open client\/server framework for the continuous collaborative improvement of deep-learning-based medical image segmentation. arXiv [Preprint] 2023."},{"key":"2026080404552160000_16.8.e119529.64","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-024-03852-4","article-title":"A 5-year natural history study in LAMA2-related muscular dystrophy and SELENON-related myopathy: the Extended LAST STRONG study","volume":"24","author":"de Laat","year":"2024","journal-title":"BMC Neurol"},{"key":"2026080404552160000_16.8.e119529.65","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1017\/cjn.2018.314","article-title":"Neuromuscular Ultrasound: Clinical Applications and Diagnostic Values","volume":"45","author":"Mah","year":"2018","journal-title":"Can J Neurol Sci"},{"key":"2026080404552160000_16.8.e119529.66","unstructured":"Pillen S , Boon A , Van Alfen N . Chapter 42 - muscle ultrasound. In: Masdeu JC , Gonz\u00e1lez RG , eds. Handbook of clinical neurology. 136. Elsevier, 2016: 843\u201353."},{"key":"2026080404552160000_16.8.e119529.67","doi-asserted-by":"publisher","DOI":"10.1179\/1743132811Y.0000000010"},{"key":"2026080404552160000_16.8.e119529.68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.24613","article-title":"Muscle ultrasound from diagnostic tool to outcome measure--Quantification is the challenge","volume":"52","author":"Pillen","year":"2015","journal-title":"Muscle Nerve"},{"key":"2026080404552160000_16.8.e119529.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.03.008"},{"key":"2026080404552160000_16.8.e119529.70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1017\/cjn.2018.269","article-title":"Neuromuscular Ultrasound: A New Tool in Your Toolbox","volume":"45","author":"van Alfen","year":"2018","journal-title":"Can J Neurol Sci"},{"key":"2026080404552160000_16.8.e119529.71","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.nmd.2023.10.015","article-title":"Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy","volume":"33","author":"Vincenten","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"2026080404552160000_16.8.e119529.72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.27081","article-title":"Muscle ultrasound: Present state and future opportunities","volume":"63","author":"Wijntjes","year":"2021","journal-title":"Muscle Nerve"},{"key":"2026080404552160000_16.8.e119529.73","unstructured":"Doorduin J . Quantitative ultrasound muscle imaging analysis software. GitHub; 2019. Available: https:\/\/github.com\/jdoorduin\/qumia.git"},{"key":"2026080404552160000_16.8.e119529.74","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10384"},{"key":"2026080404552160000_16.8.e119529.75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nmd.2024.07.001","article-title":"Improving Heckmatt muscle ultrasound grading scale through Rasch analysis","volume":"42","author":"Wijntjes","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"2026080404552160000_16.8.e119529.76","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-019-1244-3","article-title":"Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests","volume":"19","author":"Bartels","year":"2019","journal-title":"BMC Neurol"},{"key":"2026080404552160000_16.8.e119529.77","doi-asserted-by":"crossref","DOI":"10.1093\/ptj\/pzac099","article-title":"Reliability of Muscle Strength and Muscle Power Assessments Using Isokinetic Dynamometry in Neuromuscular Diseases: A Systematic Review","volume":"102","author":"van der Woude","year":"2022","journal-title":"Phys Ther"},{"key":"2026080404552160000_16.8.e119529.78","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13175285","article-title":"Feasibility and Reproducibility of Isokinetic Dynamometry in Children with Neuromuscular Diseases","volume":"13","author":"van der Woude","year":"2024","journal-title":"J Clin Med"},{"key":"2026080404552160000_16.8.e119529.79","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-6411(00)00027-4"},{"key":"2026080404552160000_16.8.e119529.80","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-199304000-00004"},{"key":"2026080404552160000_16.8.e119529.81","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20389"},{"key":"2026080404552160000_16.8.e119529.82","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1749-6632.1971.tb30759.x","article-title":"Electrical testing in myasthenia gravis","volume":"183","author":"Ozdemir","year":"1971","journal-title":"Ann N Y Acad Sci"},{"key":"2026080404552160000_16.8.e119529.83","unstructured":"Prospective natural history study of patients with myotubular myopathy and other centroNuclear myopathies (NatHis-CNM). 2023. Available: https:\/\/clinicaltrials.gov\/study\/NCT03351270#study-plan"},{"key":"2026080404552160000_16.8.e119529.84","unstructured":"A natural history study of RYR1-related disorders. n.d. Available: https:\/\/clinicaltrials.gov\/study\/NCT06287762?term=NCT06287762&rank=1"},{"key":"2026080404552160000_16.8.e119529.85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13023-024-03146-5","article-title":"Rare disease clinical trials in the European Union: navigating regulatory and clinical challenges","volume":"19","author":"Mishra","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"2026080404552160000_16.8.e119529.86","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-021-02336-z","article-title":"Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study","volume":"21","author":"Bouman","year":"2021","journal-title":"BMC Neurol"},{"key":"2026080404552160000_16.8.e119529.87","unstructured":"Early phase human drug trial to investigate dynamin 101 (DYN101) in patients \u2265 16 years with centronuclear myopathies (unite-CNM). n.d. Available: https:\/\/clinicaltrials.gov\/study\/NCT04033159?term=NCT04033159&rank=1"},{"key":"2026080404552160000_16.8.e119529.88","unstructured":"Resultaten enqu\u00eate onderzoeksagenda spierziekten Nederland: spierziekten Nederland. 2023. Available: https:\/\/www.spierziekten.nl\/fileadmin\/user_upload\/VSN\/Nieuws\/Documenten\/Resultaten_onderzoeksagenda_spierziekten_juni_2023_-_website.pdf"},{"key":"2026080404552160000_16.8.e119529.89","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13446"},{"key":"2026080404552160000_16.8.e119529.90","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1007\/s00415-022-10990-7","article-title":"Long-term follow-up of respiratory function in facioscapulohumeral muscular dystrophy","volume":"269","author":"Teeselink","year":"2022","journal-title":"J Neurol"},{"key":"2026080404552160000_16.8.e119529.91","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.clinthera.2024.03.008","article-title":"Lessons Learned From Clinical Studies in Centronuclear Myopathies: The Patient Perspective-A Qualitative Study","volume":"46","author":"Stinissen","year":"2024","journal-title":"Clin Ther"},{"key":"2026080404552160000_16.8.e119529.92","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3233\/JND-240029","article-title":"Individuals and Families Affected by RYR1-Related Diseases: The Patient\/Caregiver Perspective","volume":"11","author":"van de Camp","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"2026080404552160000_16.8.e119529.93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nmd.2023.12.014","article-title":"The experience of clinical study and trial participation in rare diseases: A scoping review of centronuclear myopathy and other neuromuscular disorders","volume":"38","author":"Stinissen","year":"2024","journal-title":"Neuromuscular Disorders"},{"key":"2026080404552160000_16.8.e119529.94","doi-asserted-by":"crossref","first-page":"105582","DOI":"10.1016\/j.nmd.2025.105582","article-title":"419PBaseline characteristics of patients with congenital myopathies from a 2-year prospective natural history study (READYCOM)","volume":"53","author":"Camp","year":"2025","journal-title":"Neuromuscular Disorders"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-119529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:56:49Z","timestamp":1785844609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-119529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":94,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,4]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2026-119529"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-119529","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}